Frontal fibrosing alopecia is a condition that is increasing in epidemic proportions, says Jerry Shapiro, M.D., in a presentation given at the 2018 AAD Summer Meeting.
While claims don’t always lead to court cases, they can lead to stress, says Stephen E. Wolverton, M.D., a dermatologist with Indiana University Health in Bloomington, Ind. Learn more about managing the stress associated with malpractice claims.
Introducing a new column called "Innovation" from the co-founders of Advancing Innovation in Dermatology Accelerator Fund. In the first installment of this series, Drs. Steve Xu and William Ju address the importance of innovation in dermatology.
False eyelashes and hair extensions could become a problem if it becomes representative of the “ideal” woman.
A new Centers for Medicaid and Medicare Services plan for payment for evaluation and management services (E/M) has been proposed and CMS is currently accepting comments through 5 p.m., Sept. 10. The new rules would apply to all E/M services delivered after Jan. 1, 2019.
Nutritional supplements should only be considered for a small subset of patients with alopecia areata, said Dr. Leslie Castelo-Soccio in a presentation from the AAD Summer Meeting.
Reproductive age women with psoriasis could benefit from an endocrinologist or obstetrician referral before starting systemic therapy.
Study shows that blocking IL-13 improves atopic dermatitis ― a promising finding for IL-13 atopic dermatitis drugs in development.
One hurdle in treating patients, particularly children and teens, is ensuring compliance with treatment protocols. It can feel like an uphill battle, but there are things you can do to improve your patients’ adherence level.
Mapping the human genome for chronic itch holds the potential to develop targeted therapy for atopic dermatitis and psoriasis itch, a study shows.
This is the first time an IL-23 blocking drug has been shown to improve signs and symptoms of psoriatic arthritis.
As dermatologists become increasingly aware of comorbidities associated with psoriasis, questions of associated malignancy risk remain. Dr. Megan Noe emphasizes the need for skin cancer checks.
Chance of metastasis for cutaneous squamous cell carcinomas of vermillion lip is five times greater than on the cutaneous lip, study shows.
Two to three months of neoadjuvant topical imiquimod, 5%, cream prior to conservatively staged excisions for lentigo maligna (LM) is associated with a low rate of recurrence.
Solid organ transplant recipients experience an average of two cutaneous squamous cell carcinomas following their transplant.
If you’re providing body contouring services to patients, chances are you’re doing it differently than you were a decade ago, according to a presentatin by Dr. Mathew Avram from the 2018 AAD Summer Meeting.
In this month's Cosmetic Conundrums column, Dr. Draelos addresses “tight skin,” the use of menthol in skin care products and over-the-counter itch relieving products.
WE medical trip to India ends in eye-opening lessons learned.
88 percent of the U.S. population has regular access to healthcare, shows an analysis by WalletHub which in August released its 2018 Best and Worst States for Health Care list.
In October, the Food and Drug Administratin is expected to decide on the approval of omadacycline (Paratek Pharmaceuticals) for the treatment of acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia.
PharmaTimes reported in August that the Spanish company Almirall acquired Allergan’s U.S. dermatology portfolio for $650 million.
Ortho Dermatologics announced in August that it resubmitted a new drug application to the FDA for DUOBRIITM1, a lotion for the treatment of plaque psoriasis.
Physicians throughout the country are recruiting patients for two phase three clinical trials of cantharidin for the treatment of molluscum contagiousum. a viral skin condition.
Topical rapamycin significantly improves facial angiofibromas secondary to tuberous sclerosis complex, according to data from a 6-month randomized placebo-controlled study.
Researchers writing in JAMA Dermatology report that patients diagnosed with hidradenitis suppurativa (HS) are at a higher risk for having or developing Crohn’s disease (CD).
Helping a dermatopathologist diagnose neoplasms and infections of the foot requires not only taking adequate samples, but in many cases, sending clinical photographs with them.
New FDA-approved treatment for raised seborrheic keratosis.
Discordance between increase in billed procedures vs increase in number of patients.
It is only recently that continued research has led to significant advances in numerous immune-based drugs that can successfully be used in patients with advanced melanoma (stage III and IV).
The new Thermage FLX adds speed and ease of use to the only monopolar radiofrequency (RF) device FDA-cleared for use on body and facial locations, including the eyelids, with a single treatment.
Pennsylvania Dermatology Partners tells its story of technological support and success.
Study of 144 female students shows that stress may increase acne severity.
Dermatologists should consider using the diuretic drug spironolactone to treat acne in women instead of antibiotics, researchers report.
Researchers writing in the Journal of Clinical and Aesthetic Dermatology outline 10 treatments for acne scarring, plus possible future treatments.
Treatment may offer an alternative to topical retinoid treatments for acne scarring.
“As dermatologists, we are trained in managing acne. We can provide early and effective treatment that improves the physical and psychological effects. It is up to us to bridge the gap between those suffering from acne and their access to medical treatment."
Monitoring changes in patients with melanoma can be tricky. Some changes present slowly and in tiny ways. Using imaging technologies to track these changes can help achieve an accurate diagnosis.